log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.
Background : T2DM is associated with atherogenic dyslipidemia (AD), defined as decreased HDL-C plus raised triglycerides (TG). AD confers increased risk for CAD, even when LDL-C is at target. AD is rarely assessed due to lack of screening methods consensus. Aim : To establish the prevalence and severity of AD from log(TG)/HDL-C in T2DM males, and to determine how it relates to cardiometabolic phenotype, glucose homeostasis, micro- and macrovascular complications, and 10-year UKPDS CV risk. Methods : 585 T2DM males divided according to quintiles (Q) of log(TG)/HDL-C. AD prevalence defined as HD... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2010 |
Verlag/Hrsg.: |
BioMed Central Ltd.
|
Schlagwörter: | Aged / Hemoglobin A / Glycosylated / Humans / Insulin / Insulin-Secreting Cells / Linear Models / Male / Metabolic Syndrome X / Middle Aged / Prevalence / Risk Assessment / Belgium / Risk Factors / Severity of Illness Index / Sex Factors / Time Factors / Triglycerides / Biological Markers / Chi-Square Distribution / Cholesterol / HDL / Cross-Sectional Studies / Diabetes Mellitus / Type 2 / Diabetic Angiopathies / Dyslipidemias |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26587834 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/132369 |